Clinical Trials Browser

OTHER × Interventional × Biological Therapy × Clear all

Carcinoma, Non-Small-Cell Lung

NCT01872819 2018-07-11

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

NCT00462189 2007-04-18

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Phase 1 Unknown

40 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell, Recurrence

NCT00457860 2007-04-17

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Phase 1 Unknown

50 enrolled

Other hematologic neoplasm

Leukemia, Recurrence

Clinical Trials

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease